Aquatet 100% W/W Premix For Medicated Feeding Stuff
Revised: May 2011
AN: 00157/2011
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Aquatet 100% w/w Premix for Medicated Feeding Stuff
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Ingredient:
Qualitative composition Quantitative composition
Oxytetracycline hydrochloride 100% w/w
For full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Premix for Medicated Feeding Stuff
A fine, bright, yellow, odourless, crystalline powder
4. CLINICAL PARTICULARS
4.1 Target species
Salmon and rainbow trout
4.2 Indications for use, specifying the target species
Treatment and control of furunculosis due to Aeromonas salmonicidaand columnaris disease in Atlantic salmon, and furunculosis and enteric redmouth disease in Rainbow trout.
4.3 Contraindications
Do not use in animals with known hypersensitivity to the active ingredient.
Do not administer together with Growth Promoters or other antibiotics
4.4 Special warnings for each target species
For fish treatment only.
4.5 Special precautions for use
Special precautions for use in animals
Medicated feed should be used for the treatment period only.
Special precautions for the person administering the veterinary medicinal product to animals.
If you know you are hypersensitive (allergic) to oxytetracycline, do not handle the product.
When handling the product, inhalation of the dust must be avoided by wearing a disposable half-mask respirator conforming to European Standard EN 149 (FFP2) or a non-disposable respirator to European Standard EN 140 with a filter to EN 143.
Avoid contact with skin and eyes. Gloves should be worn whilst handling this product. If contact with skin or eyes occurs, wash area immediately with copious amounts of fresh water. If irritation persists, seek medical attention.
Hands and exposed skin should be washed thoroughly after use.
iii. Other precautions
It is essential to obtain consent from the local regional office of the Environment Agency or SEPA before using Aquatet medicated feed.
4.6 Adverse reactions (frequency and seriousness)
No adverse effects are observed when the product is administered at recommended dose rate.
4.7 Use during pregnancy, lactation or lay
This product may be used on brood stock.
4.8 Interaction with other medicinal products and other forms of interaction
Do not administer together with Growth Promoters or other antibiotics.
4.9 |
Amount(s) to be administered and administration route |
|||||||||||
|
For oral administration. The product is given by oral administration at a rate of 75mg/kg bodyweight of fish, daily for initially 4 days. After the initial treatment, mortalities should be assessed and a further 4 days treatment course should be administered if necessary. The product is for administration only through the feed by mixing with manufactured feed prior to feeding. Feeding rates will vary according to the water temperature and it may therefore be more convenient to medicate on the basis of a fixed rate, e.g. 1% of bodyweight, with the extra daily feed requirement being met by unmedicated food. The following inclusion rates will provide the recommended dose.
Method of mixing: - Weigh out appropriate amounts of fish pellets and product and mix well together in a dry state. As an aid to the adhesion of the product to the fish pellets, a small quantity of a tepid gelatin solution of edible oil is then added to the food while mixing. Sufficient quantity should be mixed into the medicated food until it is slightly dampened. |
|||||||||||
4.10 |
Overdose (symptoms, emergency procedures, antidotes), if necessary |
|||||||||||
|
Oxytetracycline has a wide safety margin. Furthermore, the product administered onto food in this manner cannot be expected to lead to overdose. |
|||||||||||
4.11 |
Withdrawal period(s) |
|||||||||||
|
Animals must not be slaughtered for human consumption during treatment, Fish may be slaughtered for human consumption from 720° days after the last treatment. |
|||||||||||
5. |
PHARMACOLOGICAL PROPERTIES |
|||||||||||
|
Pharmacotherapeutic group: Antibacterials for systemic use (oxytetracycline) |
|||||||||||
|
ATC Vet Code: QJ01AA06 |
|||||||||||
|
|
|||||||||||
5.1 |
Pharmacodynamic properties |
|||||||||||
|
Oxytetracycline is a broad-spectrum antibiotic. It also inhibits mycoplasmas chlamydiae, rickettsiae and some protozoa. When dosed orally, it is readily absorbed and achieves effective concentrations in various tissues. |
|||||||||||
5.2 |
Pharmacokinetic properties |
|||||||||||
|
Oxytetracycline is a broad spectrum bacteriostatic agent and is used as a drug of first choice for many bacterial diseases of fish. Absorption, distribution, metabolism and elimination of Oxytetracycline varies between species of fish and is temperature and salinity dependent. Its mechanism of action is via inhibition of protein synthesis of susceptible bacteria. |
|||||||||||
6. |
PHARMACEUTICAL PARTICULARS |
|||||||||||
|
|
|||||||||||
6.1 |
List of excipients |
|||||||||||
|
None. |
|||||||||||
6.2 |
Incompatibilities |
|||||||||||
|
Aquatet is incompatible with Calcium products and certain Growth Promoters and bactericidal antibacterials. |
|||||||||||
6.3 |
Shelf life |
|||||||||||
|
Shelf life of the veterinary medicinal product as packaged for sale: 18 months. |
|||||||||||
6.4 |
Special precautions for storage |
|||||||||||
|
Store in a dry place. Store in a tightly closed original container. Do not store above 25°C. Protect from light. Due to the hydroscopic nature of the product, any open part packs of the veterinary medicinal product should be discarded and not resealed for use at a later date. Medicated feed should be prepared as required and not stored. |
|||||||||||
6.5 |
Nature and composition of immediate packaging |
|||||||||||
|
White, food grade polyethylene tub or bucket, with a white polypropylene tamper evident lid (push fit) with low density polyethylene liner. Sizes: 1kg tub, 2.5kg bucket. OR, Polyethylene liner, inside a fibreboard drum Sizes: 25kg NOT ALL PACK SIZES MAY BE MARKETED |
6.6 |
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products, if appropriate |
|
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. |
7. |
MARKETING AUTHORISATION HOLDER |
|
Pharmaq Limited Unit 15 Sandleheath Industrial Estate Fordingbridge Hants SP6 1PA |
8. |
MARKETING AUTHORISATION NUMBER(S) |
|
Vm 11003/4002 |
9. |
DATE OF FIRST AUTHORISATION |
|
Date: 14th March 1994 |
10. |
DATE OF REVISION OF THE TEXT |
|
Date: May 2011 |
Page 5 of 5